BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/6/2016 4:13:00 PM | Browse: 570 | Download: 726
Publication Name World Journal of Gastroenterology
Manuscript ID 20342
Country/Territory Japan
Received
2015-06-02 09:21
Peer-Review Started
2015-06-03 13:14
To Make the First Decision
2015-07-20 13:57
Return for Revision
2015-07-28 11:26
Revised
2015-08-13 12:56
Second Decision
2015-09-23 19:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-09-30 08:52
Articles in Press
2015-09-30 08:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
2015-11-05 07:05
Typeset the Manuscript
2015-12-18 17:36
Publish the Manuscript Online
2016-01-06 16:13
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies
Manuscript Source Invited Manuscript
All Author List Tasuku Matsuoka and Masakazu Yashiro
Funding Agency and Grant Number
Funding Agency Grant Number
Grant-in-Aid for Scientific Research 23390329 (in part)
Corresponding author Masakazu Yashiro, MD, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. m9312510@med.osaka-cu.ac.jp
Keywords Pancreatic cancer; Targeted therapy; Tyrosine kinase inhibitors; Microenvironment; Cancer stem cell
Core Tip Pancreatic cancer-related mortality is almost consistently caused by local recurrence and metastasis. The survival of patients after surgical resection remains poor, and the results of adjuvant chemotherapy and radiotherapy are still unsatisfactory. Therefore, new treatments are urgently needed. Recent developments in our knowledge of the underlying biological features of pancreatic cancer may be useful in establishing molecularly targeted therapy as a new strategy, similar to those used to treat other types of malignancies.
Publish Date 2016-01-06 16:13
Citation Matsuoka T, Yashiro M. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies. World J Gastroenterol 2016; 22(2): 776-789
Url http://www.wjgnet.com/1007-9327/full/v22/i2/776.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i2.776
Full Article (PDF) WJG-22-776.pdf
Full Article (Word) WJG-22-776.doc
Manuscript File 20342-Review.docx
Answering Reviewers 20342-Answering reviewers.pdf
Audio Core Tip 20342-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 20342-Conflict-of-interest statement.pdf
Copyright License Agreement 20342-Copyright assignment.pdf
Peer-review Report 20342-Peer-review(s).pdf
Scientific Misconduct Check 20342-Scientific misconduct check.pdf
Scientific Editor Work List 20342-Scientific editor work list.pdf